{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/492829921"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/119816164" ] } },

    { "id" : "http://webisa.webdatacommons.org/119816164"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "(1600) Hon. Ron Cannan: what is the main difference in pharmaceutical patent protection, then, between Canada and other TPP countries, most notably the United States?" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "parl.gc.ca" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/396865772"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/119816164"] } } }
